JP2002062294A - Method and device for measuring skin surface condition - Google Patents

Method and device for measuring skin surface condition

Info

Publication number
JP2002062294A
JP2002062294A JP2000252732A JP2000252732A JP2002062294A JP 2002062294 A JP2002062294 A JP 2002062294A JP 2000252732 A JP2000252732 A JP 2000252732A JP 2000252732 A JP2000252732 A JP 2000252732A JP 2002062294 A JP2002062294 A JP 2002062294A
Authority
JP
Japan
Prior art keywords
skin
culture solution
potential difference
measuring
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000252732A
Other languages
Japanese (ja)
Other versions
JP3860956B2 (en
Inventor
Mitsuhiro Denda
光洋 傳田
Yutaka Ashida
豊 芦田
Kaori Inoue
かおり 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2000252732A priority Critical patent/JP3860956B2/en
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to DE60136195T priority patent/DE60136195D1/en
Priority to US10/362,127 priority patent/US20040106877A1/en
Priority to PCT/JP2001/007142 priority patent/WO2002016933A1/en
Priority to EP01956991A priority patent/EP1314979B1/en
Priority to EP07008527A priority patent/EP1811296A1/en
Priority to KR10-2003-7002542A priority patent/KR100880560B1/en
Priority to TW090120657A priority patent/TW584725B/en
Publication of JP2002062294A publication Critical patent/JP2002062294A/en
Application granted granted Critical
Publication of JP3860956B2 publication Critical patent/JP3860956B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method and a device for measuring a skin surface condition so as to measure and digitize a human sense given by a stimulation to the skin surface and to provide a method and a device for measuring effect of a protective drug against the sense if the sense is mentally minus. SOLUTION: A skin section is floated on the surface of a culture solution stored in a vessel with the skin section surface side directed upward, and a potential difference between the skin section skin surface and the culture solution is measured. By giving stimulation to the skin surface or adding a stimulant to the culture solution, the potential difference is measured for measuring the degree of stimulation to the skin. By applying the drug to the skin section after giving the stimulation to the skin surface or adding the stimulant to the culture solution, the potential difference is measured for measuring the degree of reduction of skin stimulation due to the drug. By adding the drug to the culture solution after giving the stimulation to the skin surface or adding the stimulant to the culture solution, the potential difference is measured for measuring the degree of reduction of skin stimulation due to the drug.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、皮膚表面の状態を
測定する方法及びそれらを測定する装置に関する。さら
に詳しくは、培養液の液面に表面を上にして皮膚切片を
浮かべた皮膚モデルを作成し、その皮膚表面と培養液と
の電位差から皮膚表面の状態を測定する方法、また、皮
膚表面あるいは培養液に刺激要因を与えて変化する電位
差から刺激度を測定する方法、さらにこれらの刺激皮膚
に薬剤を加えた時の電位差の変化から皮膚刺激の抑制度
を測定する方法、並びにこれらの方法を実施するに適し
た装置に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for measuring the condition of the skin surface and an apparatus for measuring the same. More specifically, a method of creating a skin model in which a skin slice is floated with the surface facing up on the surface of the culture solution and measuring the state of the skin surface from the potential difference between the skin surface and the culture solution, A method for measuring the degree of irritation from a potential difference that changes by giving a stimulating factor to a culture solution, a method for measuring the degree of inhibition of skin irritation from a change in the potential difference when a drug is added to these irritating skin, and these methods A device suitable for implementation.

【0002】[0002]

【従来の技術】ヒトの皮膚表面は自然界からさまざまな
刺激を受けている。刺激を受けた場合、皮膚に症状とし
て現れると同時にかゆみ、いたみ、ひりつき等のような
ヒトの感覚で表現されるものが生じる場合が多く、ま
た、症状が現れず感覚のみのものも多くある。これらの
刺激には快適なものもあるが、不快なものも多く、例え
ばかゆみ等の刺激は、ヒトにとって不快なものである。
これらの刺激はヒトの感覚の範疇であり、他人には分か
らない厄介なものでもある。
2. Description of the Related Art The surface of human skin is subjected to various stimuli from nature. When irritated, it often appears as a symptom on the skin, and at the same time, there are many things that are expressed by human sensations, such as itching, itching, and sticking, and there are also many things that do not show any symptoms but only sensation . Some of these stimuli are comfortable, but many are unpleasant, and stimuli such as itching are unpleasant for humans.
These stimuli are in the category of human sensation and can be awkward to others.

【0003】しかしながら、従来皮膚の表面状態を測定
する方法がなかったため感覚の度合をヒトの訴えに頼ら
ざるを得なかった。したがって、そのような刺激を客観
性のある数値等に置き換えられれば主観的な感覚の共有
化ができ、さらに上記数値等を使えば不快な刺激の抑制
薬剤の開発速度が急転することが期待される。
[0003] However, there has been no method for measuring the surface condition of the skin in the past, so that the degree of sensation had to rely on human complaints. Therefore, if such a stimulus can be replaced with an objective numerical value or the like, it is possible to share a subjective sensation, and further, if the above numerical value or the like is used, the development speed of an unpleasant stimulus suppressing drug is expected to rapidly change. You.

【0004】[0004]

【発明が解決しようとする課題】本発明は上記事情に鑑
みてなされたもので、その目的は、皮膚の表面状態を測
定する方法と装置を提供することにあり、特に、皮膚表
面への刺激がもたらすヒトの感覚を測定して数値化する
こと、さらに、感覚がヒトにとって精神的にマイナスで
ある場合に、それを防御する薬剤の効果を測定するため
の方法とそれらに用いる装置を提供することにある。
SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and it is an object of the present invention to provide a method and an apparatus for measuring the surface condition of the skin. The present invention provides a method for measuring and quantifying a human sensation caused by a human being, and a method for measuring the effect of a drug that protects the sensation when the sensation is mentally negative for a human, and an apparatus for use in the method. It is in.

【0005】[0005]

【課題を解決するための手段】本発明者らは、皮膚表面
の電位に注目することにより、上記課題を解決しようと
試みた。そして、培養液の液面に表面を上にして皮膚切
片を浮かべた簡便な皮膚モデルを作成し、皮膚表面と培
養液との電位差を簡便に測定できる方法を見出しこれを
活用することにより上記課題を解決した。
Means for Solving the Problems The present inventors have attempted to solve the above problems by focusing on the potential of the skin surface. Then, a simple skin model was created in which a skin slice was floated with the surface facing up on the liquid surface of the culture solution, and a method capable of easily measuring the potential difference between the skin surface and the culture solution was found. Was solved.

【0006】すなわち、本発明による皮膚表面状態測定
方法は、容器内に収容した培養液の液面に表面を上にし
て皮膚切片を浮かべ、この皮膚切片の皮膚表面と前記培
養液との電位差を測定することを特徴とする。
That is, according to the method for measuring the condition of the skin surface according to the present invention, a skin slice is floated on the surface of a culture solution contained in a container with the surface facing upward, and the potential difference between the skin surface of the skin slice and the culture solution is determined. It is characterized by measuring.

【0007】また、容器内に収容した培養液の液面に表
面を上にして皮膚切片を浮かべ、この皮膚切片の皮膚表
面と前記培養液との電位差を測定するに当たって、皮膚
表面に刺激を与えて電位差を測定し、その値と、刺激を
与えない場合の電位差との差から、皮膚の刺激度を測定
することを特徴とする。
[0007] Further, a skin slice is floated on the surface of the culture solution contained in the container with the surface facing upward, and when the potential difference between the skin surface of the skin slice and the culture solution is measured, the skin surface is stimulated. And a potential difference between the measured value and the potential difference when no stimulus is given.

【0008】本発明の皮膚刺激度の測定において、前記
刺激は、刺激物質または物理的刺激によることができ
る。
[0008] In the measurement of the degree of skin irritation of the present invention, the stimulus may be a stimulus substance or a physical stimulus.

【0009】また、容器内に収容した培養液の液面に表
面を上にして皮膚切片を浮かべ、この皮膚切片の皮膚表
面と前記培養液との電位差を測定するに当たって、培養
液に刺激物質を添加して電位差を測定し、その値と、刺
激物質を添加しない場合の電位差との差から、皮膚の刺
激度を測定することを特徴とする。
[0009] Further, a skin slice is floated on the surface of the culture solution contained in the container with its surface facing upward, and in measuring the potential difference between the skin surface of the skin slice and the culture solution, an irritant is added to the culture solution. It is characterized in that the potential difference is measured after addition, and the degree of skin irritation is measured from the difference between the value and the potential difference when no stimulant is added.

【0010】これら、前記皮膚の刺激度の測定に当たっ
て用いられる刺激物質で最も典型的なものはかゆみ発生
物質である。
The most typical irritants used for measuring the degree of irritation of the skin are itch-generating substances.

【0011】また、容器内に収容した培養液の液面に表
面を上にして刺激を与えた皮膚切片を浮かべ、この皮膚
切片の皮膚表面と前記培養液との電位差を測定するに当
たって、皮膚表面に刺激を与える前あるいは後に、その
皮膚表面に薬剤を塗布して電位差を測定し、その値と、
薬剤を塗布しない場合の電位差との差から、薬剤による
皮膚刺激の抑制度を測定することを特徴とする。
In addition, a stimulated skin slice is floated on the surface of the culture solution contained in the container with its surface facing upward, and the potential difference between the skin surface of the skin slice and the culture solution is measured. Before or after applying a stimulus to the skin surface, apply a drug to the skin surface and measure the potential difference.
The method is characterized in that the degree of inhibition of skin irritation by a drug is measured from the difference from the potential difference when the drug is not applied.

【0012】さらに、容器内に収容した培養液の液面に
表面を上にして刺激を与えた皮膚切片を浮かべ、この皮
膚切片の皮膚表面と前記培養液との電位差を測定するに
当たって、皮膚表面に刺激を与える前あるいは後に、培
養液に薬剤を添加して電位差を測定し、その値と、薬剤
を添加しない場合の電位差との差から、薬剤による皮膚
刺激の抑制度を測定することを特徴とする。
Further, a stimulated skin slice is floated on the surface of the culture solution contained in the container with its surface facing upward, and the potential difference between the skin surface of the skin slice and the culture solution is measured. Before or after stimulating the skin, a drug is added to the culture solution to measure the potential difference, and the degree of inhibition of skin irritation by the drug is measured from the difference between the value and the potential difference when no drug is added. And

【0013】本発明の皮膚刺激抑制度の測定において、
前記刺激は、刺激物質または物理的刺激によることがで
きる。
In the measurement of the degree of inhibition of skin irritation according to the present invention,
The stimulus can be a stimulus or a physical stimulus.

【0014】また、容器内に収容した刺激物質を添加し
た培養液の液面に表面を上にして皮膚切片を浮かべ、こ
の皮膚切片の皮膚表面と前記培養液との電位差を測定す
るに当たって、培養液に刺激物質を添加する前あるいは
後に、その皮膚表面に薬剤を塗布して電位差を測定し、
その値と、薬剤を塗布しない場合の電位差との差から、
薬剤による皮膚刺激の抑制度を測定することを特徴とす
る。
Further, a skin slice is floated on the surface of the culture solution containing the stimulant contained in the container with the surface facing upward, and the potential difference between the skin surface of the skin slice and the culture solution is measured. Before or after adding the stimulant to the solution, apply a drug to the skin surface and measure the potential difference,
From the difference between that value and the potential difference when the drug is not applied,
It is characterized in that the degree of inhibition of skin irritation by a drug is measured.

【0015】さらに、容器内に収容した刺激物質を添加
した培養液の液面に表面を上にして皮膚切片を浮かべ、
この皮膚切片の皮膚表面と前記培養液との電位差を測定
するに当たって、培養液に刺激物質を添加する前あるい
は後に、培養液に薬剤を添加して電位差を測定し、その
値と、刺激物質を添加しない場合の電位差との差から、
薬剤による皮膚刺激の抑制度を測定することを特徴とす
る。
Further, the skin slice is floated on the surface of the culture solution containing the stimulant contained in the container, with the surface facing upward.
In measuring the potential difference between the skin surface of the skin slice and the culture solution, before or after adding the stimulant to the culture solution, a drug is added to the culture solution to measure the potential difference, and the value and the stimulus substance are measured. From the difference from the potential difference when not added,
It is characterized in that the degree of inhibition of skin irritation by a drug is measured.

【0016】前記皮膚刺激の抑制度の測定に当たって用
いられる刺激物質で最も典型的なものはかゆみ発生物質
である。
The most typical irritants used for measuring the degree of inhibition of the skin irritation are itching substances.

【0017】このような皮膚表面状態測定方法を実施す
るための装置は、培養液と、その液面に表面を上にして
浮かべた皮膚切片を収容した容器と、前記培養液に連絡
される標準電極部と、前記皮膚切の皮膚表面に連絡され
る測定電極部と、前記標準電極部と前記測定電極部との
電位差を検出する電位差検出部とを備えたことを特徴と
する。
An apparatus for carrying out such a skin surface condition measuring method comprises a container containing a culture solution, a skin section floating on the surface of the culture solution, and a standard device connected to the culture solution. An electrode unit, a measurement electrode unit connected to the skin surface of the skin cut, and a potential difference detection unit that detects a potential difference between the standard electrode unit and the measurement electrode unit.

【0018】本発明の皮膚表面状態測定装置に用いられ
る好ましい標準電極部は、標準電極が浸漬された内部液
を収容した内チューブと、この内チューブを中に収納し
二重チューブを形成する、内部液を収容した外チューブ
とを備え、前記内チューブ壁には液絡が被着されてなる
ことを特徴とする標準電極部である。
A preferred standard electrode portion used in the skin surface condition measuring apparatus of the present invention is an inner tube containing an internal liquid in which the standard electrode is immersed, and a double tube formed by containing the inner tube therein. An outer tube containing an inner liquid, wherein a liquid junction is attached to a wall of the inner tube.

【0019】この場合の前記培養液と標準電極部との連
絡は、前記培養液と、前記外チューブ内の内部液との間
に結ばれた塩橋による。
In this case, the communication between the culture solution and the standard electrode section is made by a salt bridge connected between the culture solution and the internal solution in the outer tube.

【0020】また、本発明の皮膚表面状態測定装置に用
いられる前記測定電極部としては、測定電極が浸漬され
た内部液を収容した内チューブと、この内チューブを中
に収納し二重チューブを形成する、内部液を収容した外
チューブとを備え、前記内チューブ壁には液絡が被着さ
れてなることを特徴とする測定電極部を用いることがで
きる。
The measuring electrode section used in the skin surface condition measuring apparatus of the present invention includes an inner tube containing an internal liquid in which the measuring electrode is immersed, and a double tube containing the inner tube therein. An outer tube containing an internal liquid to be formed is provided, and a liquid junction is attached to the inner tube wall.

【0021】この場合の前記皮膚切片の皮膚表面と測定
電極部との連絡は、前記皮膚切片の皮膚表面と、前記外
チューブ内の内部液との間に結ばれた塩橋による。
In this case, communication between the skin surface of the skin slice and the measuring electrode unit is performed by a salt bridge connected between the skin surface of the skin slice and the internal liquid in the outer tube.

【0022】なお、前記各方法及び装置で用いる培養液
は、生理食塩水又はアミノ酸類を含む培養液であること
が好ましい。
The culture solution used in each of the above methods and apparatuses is preferably a physiological saline solution or a culture solution containing amino acids.

【0023】前記のような本発明による皮膚表面状態測
定方法と装置によれば、皮膚切片の皮膚表面と皮膚切片
を浮かべた培養液との電位差を好適な装置を用いて測定
することにより、皮膚表面の状態を簡便に測定すること
ができる。また、皮膚表面あるいは培養液に刺激要因を
与えて前記電位差の変化を測定することにより、ヒトを
直接使用することなく、しかもヒトの主観を越えて、刺
激を客観的に表すことができる。さらに、薬剤添加によ
る前記電位差の変化から皮膚刺激に対して有効な薬剤の
探索に活用でき、新薬剤探索に対して大幅な効果を図る
ことができ、非常に有用である。
According to the method and apparatus for measuring the surface condition of the skin according to the present invention as described above, the potential difference between the skin surface of the skin section and the culture solution on which the skin section floats is measured by using a suitable apparatus, whereby the skin is measured. The state of the surface can be easily measured. In addition, by applying a stimulus factor to the skin surface or the culture solution and measuring the change in the potential difference, the stimulus can be objectively expressed without using a human directly and beyond the human subjectivity. Further, the change in the potential difference due to the addition of a drug can be used for searching for a drug effective against skin irritation, and a great effect can be achieved for searching for a new drug, which is very useful.

【0024】なお、本発明において、前記皮膚表面状態
とは、皮膚表面で起こるさまざまな状態変化をも含めた
概念であり、例えば刺激、刺激の抑制等による状態変化
及びその度合をも含めたものである。
In the present invention, the skin surface condition is a concept including various state changes occurring on the skin surface, and includes, for example, a state change due to irritation, suppression of irritation and the like, and a degree thereof. It is.

【0025】[0025]

【発明の実施の形態】以下、本発明の方法、本発明の装
置の順に説明する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The method of the present invention and the device of the present invention will be described below in this order.

【0026】本発明の第一の方法は、容器内に収容した
培養液の液面に表面を上にして皮膚切片を浮かべ、この
皮膚切片の皮膚表面と前記培養液との電位差(mV)を
測定する。これにより、皮膚の表面状態が測定される。
In the first method of the present invention, a skin slice is floated on the surface of a culture solution contained in a container with its surface facing upward, and the potential difference (mV) between the skin surface of the skin slice and the culture solution is determined. Measure. Thereby, the surface condition of the skin is measured.

【0027】本発明の第二の方法は、第一方法の皮膚表
面状態の測定に当たって、さらに皮膚切片と培養液から
なる皮膚モデルに刺激を与えて前記電位差を測定する。
この電位差は、刺激を加えることによって変化する。こ
の変化は表皮の中にイオンの流れが発生したことを意味
する。刺激によってイオンの流れの方向が異なる。未処
理の皮膚の値に比べて変化があれば、表皮にイオンの動
きを発生させる刺激が与えられたと解釈する。その変化
値から皮膚の刺激度が測定される。刺激を与えるに当た
っては、その場所は皮膚表面でも培養液でもいずれでも
よい。皮膚表面の場合は、刺激の与え方として、刺激物
質の皮膚への塗布、物理的な刺激等がとられる。また、
培養液の場合は刺激物質の添加の方法がとられる。これ
らの刺激物質としては、神経ペプチド、ヒスタミン、界
面活性剤、有機酸、カプサイシン等が挙げられる。これ
らの中、神経ペプチドとしては、サブスタンスP等があ
る。本発明においては、刺激物質がかゆみ発生物質であ
ることが特に有用である。また、前記物理的刺激の例と
しては、セロテープ(登録商標)によるバリアー破壊等
による例等がある。
In the second method of the present invention, in measuring the skin surface condition in the first method, a stimulus is further applied to a skin model comprising a skin slice and a culture solution to measure the potential difference.
This potential difference is changed by applying a stimulus. This change means that a flow of ions has occurred in the epidermis. The direction of ion flow differs depending on the stimulus. If there is a change compared to the value of the untreated skin, it is interpreted that a stimulus that causes the movement of ions to the epidermis was given. The degree of skin irritation is measured from the change value. In applying the stimulus, the location may be either the skin surface or the culture solution. In the case of the skin surface, the stimulus may be applied by applying an irritant to the skin, by physical stimulation, or the like. Also,
In the case of a culture solution, a method of adding a stimulant is used. These stimulants include neuropeptides, histamine, surfactants, organic acids, capsaicin and the like. Among these, there are substance P and the like as neuropeptides. In the present invention, it is particularly useful that the stimulant is an itch-generating substance. Examples of the physical stimulus include an example of barrier destruction by Cellotape (registered trademark) and the like.

【0028】本発明の第三の方法は、第二の方法で刺激
を与えた皮膚の薬剤添加による抑制度を測定する方法で
ある。本発明においては、前記皮膚モデル系に刺激を与
えた後、薬剤を添加して前記電位差を測定し、添加によ
って変化する電位差の値から薬剤の皮膚刺激の抑制度を
測定するものである。
The third method of the present invention is a method for measuring the degree of inhibition of the skin stimulated by the second method due to the addition of a drug. In the present invention, after applying a stimulus to the skin model system, a drug is added, the potential difference is measured, and the degree of suppression of skin irritation of the drug is measured from the value of the potential difference changed by the addition.

【0029】薬剤の添加方法によって本方法はいろいろ
な方法をとることができる。すなわち、 (1);皮膚表面に刺激を与えた皮膚切片を表面を上に
して培養液に浮かべ、皮膚刺激を与える前あるいは後に
皮膚表面に薬剤を塗布して電位差を測定し、薬剤塗布に
よって変化する電位差の値から薬剤の皮膚刺激の抑制度
を測定する。(2);(1)の皮膚表面に薬剤を塗布す
る代わりに培養液に薬剤を添加して電位差を測定し、培
養液への薬剤添加によって変化する電位差の値から薬剤
の皮膚刺激の抑制度を測定する。(3);刺激物質を添
加した培養液に皮膚切片を表面を上にして浮かべ、刺激
物質を添加する前あるいは後に皮膚表面に薬剤を塗布し
て電位差を測定し、薬剤塗布によって変化する電位差の
値から薬剤の皮膚刺激の抑制度を測定する。(4);
(3)の皮膚表面に薬剤を塗布する代わりに培養液に薬
剤を添加して電位差を測定し、培養液への薬剤添加によ
って変化する電位差の値から薬剤の皮膚刺激の抑制度を
測定する。
This method can take various methods depending on the method of adding the drug. (1); Float the skin section with the skin surface stimulated on the culture solution with the surface facing up, apply a drug to the skin surface before or after applying the skin irritation, measure the potential difference, and change with the drug application The degree of inhibition of skin irritation of the drug is measured from the value of the potential difference. (2); instead of applying the drug to the skin surface of (1), the drug is added to the culture solution to measure the potential difference, and the degree of inhibition of skin irritation of the drug is determined from the value of the potential difference that changes with the addition of the drug to the culture solution. Is measured. (3); Float the skin slice on the culture solution to which the stimulant has been added, apply a drug to the skin surface before or after adding the stimulus, measure the potential difference, and determine the potential difference that changes due to application of the drug. The degree of inhibition of skin irritation of the drug is measured from the value. (4);
Instead of applying the drug to the skin surface in (3), the drug is added to the culture solution and the potential difference is measured, and the degree of inhibition of the skin irritation of the drug is measured from the value of the potential difference changed by the addition of the drug to the culture solution.

【0030】また、前記薬剤の塗布は、刺激を与える前
でも後でも構わない。薬剤の塗布が刺激を与えた後であ
れば、刺激を緩和する効果として測定でき、また刺激を
与える前であれば、刺激を未然に防止する効果として測
定できる。
The application of the drug may be performed before or after applying the stimulus. If the application of the drug is after applying the stimulus, it can be measured as an effect to relieve the stimulus, and before applying the stimulus, it can be measured as an effect to prevent the stimulus.

【0031】第一乃至第三の測定方法において用いられ
る培養液は、生理食塩水、アミノ酸類などを含む水溶液
等が用いられる。また、測定に用いる皮膚切片は、培養
皮膚、成形手術等の際得られるヒト皮膚、ヘアレスマウ
ス等の動物由来の皮膚等を用いることができる。
As the culture solution used in the first to third measurement methods, physiological saline, an aqueous solution containing amino acids and the like are used. The skin slice used for the measurement may be cultured skin, human skin obtained in plastic surgery or the like, animal-derived skin such as a hairless mouse, or the like.

【0032】ヒトの皮膚が刺激を受けた場合、皮膚に症
状として現れると同時にかゆみ、いたみ、ひりつき等の
ようなヒトの感覚で表現されるものが生じる場合が多
く、また、症状が現れず感覚のみのものも多くある。本
発明の前記第一乃至第三の方法によれば、このような主
観的な感覚が客観性のある数値として表すことができる
ので、例えばヒトを使うことなく刺激を緩和あるいは抑
制する薬剤の探索に活用することができ、新薬剤の開発
に大いに貢献することができる。
When the skin of a person is stimulated, it often appears as a symptom on the skin, and at the same time, a thing expressed by human sensations such as itching, itching, and tingling occurs. There are many things that are only sensations. According to the first to third methods of the present invention, since such a subjective sensation can be expressed as an objective value, for example, a search for a drug that relieves or suppresses a stimulus without using humans It can greatly contribute to the development of new drugs.

【0033】次に、本発明の方法に好ましく用いられる
装置について、図面を参照しながら説明する。
Next, an apparatus preferably used in the method of the present invention will be described with reference to the drawings.

【0034】図1は、本発明における皮膚表面状態測定
装置の例を示すものである。図1に示す通り、皮膚表面
状態測定装置は、培養液1と、その液面に表面を上にし
て浮かべた皮膚切片2を収容した容器3と、前記培養液
1に連絡される標準電極部4と、前記皮膚切片2の皮膚
表面に連絡される測定電極部5と、前記標準電極部4と
前記測定電極部5との電位差を検出する電位差検出部6
とを有する。
FIG. 1 shows an example of a skin surface condition measuring apparatus according to the present invention. As shown in FIG. 1, the skin surface condition measuring device comprises a container 3 containing a culture solution 1, a skin section 2 floating on the surface of the culture solution 1, and a standard electrode section connected to the culture solution 1. 4, a measuring electrode unit 5 connected to the skin surface of the skin section 2, and a potential difference detecting unit 6 for detecting a potential difference between the standard electrode unit 4 and the measuring electrode unit 5.
And

【0035】標準電極部4は、プラスチック製の二重の
外チューブ41及び内チューブ42を有し、内チューブ
42のチューブ壁には溶液は通過させないが電子もしく
はイオンは通過させる機能を持った多孔質セラミックか
らなる液絡43を有している。この二重の外チューブ4
1及び内チューブ42の内部には、所定濃度のKCl溶
液からなる内部液44、45がそれぞれ満たされてお
り、内チューブ42の内部液45に銀−塩化銀からなる
標準電極46が浸漬されている。この標準電極46は、
二重の外チューブ41及び内チューブ42の上端を閉じ
るキャップを兼ねた電極ホルダ47に取り付けられ、そ
こから導体を介して吊り下げられた状態で内チューブ4
2内の内部液45に浸漬されている。外チューブ41の
上端寄りの周面には、その外チューブ41内に内部液4
4を補充する液補充口48が設けられている。
The standard electrode section 4 has a double outer tube 41 and an inner tube 42 made of plastic, and a porous wall having a function of allowing the solution to pass through the tube wall of the inner tube 42 but not allowing the passage of electrons or ions. And a liquid junction 43 made of high quality ceramic. This double outer tube 4
1 and the inside of the inner tube 42 are filled with internal solutions 44 and 45 each consisting of a KCl solution of a predetermined concentration, and a standard electrode 46 made of silver-silver chloride is immersed in the internal solution 45 of the inner tube 42. I have. This standard electrode 46
The inner tube 4 is attached to an electrode holder 47 also serving as a cap for closing the upper ends of the double outer tube 41 and the inner tube 42, and suspended therefrom via a conductor.
2 is immersed in the internal liquid 45. On the peripheral surface near the upper end of the outer tube 41, the inner liquid 4
A liquid replenishing port 48 for replenishing the liquid 4 is provided.

【0036】なお、図1の標準電極部4において、二重
の外チューブ41及び内チューブ42はいずれもガラス
製を使用することもできる。また、液絡43はゼラチ
ン、寒天等で擬晶構造をもたせた溶液など公知のものや
多孔質のバイコールガラス等塩橋として用いられるもの
も含めて使用することができる。また、前記標準電極4
6はカロメルからなる電極を用いても構わない。また、
内部液45にはKCl溶液以外に、塩化ナトリウム、塩
化リチウム等の塩化物の溶液が使用できる。外チューブ
41内の内部液44は、前記内チューブ42内の内部液
45に用いられる塩化物以外に生理食塩水でもよい。
In the standard electrode section 4 shown in FIG. 1, both the double outer tube 41 and the inner tube 42 may be made of glass. The liquid junction 43 may be a known one such as a solution having a pseudocrystal structure made of gelatin, agar, or the like, or a liquid junction used as a salt bridge such as porous Vycor glass. In addition, the standard electrode 4
6 may use an electrode made of calomel. Also,
In addition to the KCl solution, a chloride solution such as sodium chloride and lithium chloride can be used as the internal solution 45. The internal liquid 44 in the outer tube 41 may be a physiological saline in addition to the chloride used for the internal liquid 45 in the inner tube 42.

【0037】測定電極部5は、前記標準電極部4と同様
の構造を有している。すなわち、プラスチック製の二重
の外チューブ51及び内チューブ52を有し、内チュー
ブ52のチューブ壁には多孔質セラミックからなる液絡
53を有している。この二重の外チューブ51及び内チ
ューブ52の内部には、所定濃度のKCl溶液からなる
内部液54、55がそれぞれ満たされており、内チュー
ブ52の内部液55に銀−塩化銀からなる測定電極56
が浸漬されている。この測定電極56は、二重の外チュ
ーブ51及び内チューブ52の上端を閉じるキャップを
兼ねた電極ホルダ57に取り付けられ、そこから導体を
介して吊り下げられた状態で内チューブ52内の内部液
55に浸漬されている。外チューブ51の上端寄りの周
面には、その外チューブ51内に内部液54を補充する
液補充口58が設けられている。
The measuring electrode section 5 has the same structure as the standard electrode section 4. That is, it has a double outer tube 51 and an inner tube 52 made of plastic, and has a liquid junction 53 made of porous ceramic on the tube wall of the inner tube 52. The insides of the double outer tube 51 and the inner tube 52 are filled with internal solutions 54 and 55 each composed of a KCl solution having a predetermined concentration, and the internal solution 55 of the inner tube 52 is composed of silver-silver chloride. Electrode 56
Is immersed. The measurement electrode 56 is attached to an electrode holder 57 which also serves as a cap for closing the upper ends of the double outer tube 51 and the inner tube 52, and the inner electrode 52 in the inner tube 52 is suspended therefrom via a conductor. 55. A liquid replenishing port 58 for replenishing the inner liquid 54 into the outer tube 51 is provided on a peripheral surface near the upper end of the outer tube 51.

【0038】なお、図1の測定電極部5においても、前
記標準電極部4と同様の実施態様をとることができる。
すなわち、二重の外チューブ51及び内チューブ52は
いずれもガラス製を使用することもできる。また、液絡
53は多孔質のバイコールガラスを用いることもでき
る。また、前記測定電極56はカロメルからなる電極を
用いても構わない。また、内部液55にはKCl溶液以
外に、塩化ナトリウム、塩化リチウム等の塩化物の溶液
が使用できる。外チューブ51内の内部液54は、前記
内部液55に用いられる塩化物以外に生理食塩水でもよ
い。
The measuring electrode unit 5 shown in FIG. 1 can have the same embodiment as the standard electrode unit 4.
That is, both of the double outer tube 51 and the inner tube 52 can be made of glass. Also, the liquid junction 53 may be made of porous Vycor glass. Further, the measurement electrode 56 may be an electrode made of calomel. In addition to the KCl solution, a solution of a chloride such as sodium chloride or lithium chloride can be used as the internal solution 55. The internal solution 54 in the outer tube 51 may be a physiological saline solution other than the chloride used for the internal solution 55.

【0039】さらに、図1における標準電極部4は、そ
の外チューブ41内の内部液44に浸漬された柔軟性の
あるプラスチックチューブを生理食塩水を含むアガロー
スで満たした塩橋7を介してDMEM(Dulbecco’s mo
dified Eagle’s medium)からなる培養液1と連絡され
る。このDMEMはアミノ酸類を含んだ公知の培養液で
あり、市販品として入手できる。この他、生理食塩水を
含んだもの等公知のものを用いることもできる。また、
塩橋7は公知のものでよく、例えばシリコーン等のゴム
チューブ等も使用できる。
Further, the standard electrode section 4 in FIG. 1 is connected to a flexible plastic tube immersed in the internal solution 44 in the outer tube 41 via a salt bridge 7 filled with agarose containing physiological saline, and then the DMEM is provided. (Dulbecco's mo
(dified Eagle's medium). This DMEM is a known culture solution containing amino acids, and is available as a commercial product. In addition, known substances such as those containing physiological saline can be used. Also,
The salt bridge 7 may be a known one, for example, a rubber tube made of silicone or the like can be used.

【0040】また、測定電極部5は、その外チューブ5
1内の内部液54に浸漬された柔軟性のあるプラスチッ
クチューブを生理食塩水を含むアガロースで満たした塩
橋8を介して皮膚切片2の皮膚表面と表面上に置かれた
ろ紙9を通じて連絡されている。このろ紙9は塩橋8の
皮膚切片2の皮膚表面への接触を均一にするためであ
る。なお、塩橋8は公知のものでよく、例えばシリコー
ン等のゴムチューブ等も使用できる。
The measuring electrode section 5 is provided with an outer tube 5
The flexible plastic tube immersed in the internal liquid 54 in the container 1 is connected to the skin surface of the skin section 2 via a salt bridge 8 filled with agarose containing physiological saline and a filter paper 9 placed on the surface. ing. This filter paper 9 is for uniform contact of the skin section 2 of the salt bridge 8 with the skin surface. The salt bridge 8 may be a known one, for example, a rubber tube made of silicone or the like can be used.

【0041】前記標準電極部4の標準電極46と測定電
極部5の測定電極56は、電位差検出部6に接続され、
その間の電位差が測定される。
The standard electrode 46 of the standard electrode unit 4 and the measuring electrode 56 of the measuring electrode unit 5 are connected to the potential difference detecting unit 6,
The potential difference between them is measured.

【0042】なお、皮膚表面状態測定装置における標準
電極部として、図1の標準電極部4の外チューブ41の
チューブ壁に液絡を設けたものを用いることができる。
外チューブには、図1と同様内部液を補充する液補充口
を設けてもよい。
As the standard electrode section in the skin surface condition measuring apparatus, a standard electrode section having a liquid junction formed on the tube wall of the outer tube 41 of the standard electrode section 4 in FIG. 1 can be used.
The outer tube may be provided with a liquid replenishing port for replenishing the internal liquid as in FIG.

【0043】この標準電極部は、図1における皮膚表面
状態測定装置の標準電極部4と同様の機能をもって、図
1の標準電極部4に代えて使用できる。ただし、培養液
との連絡は、この標準電極部が培養液に浸漬され、外チ
ューブ壁に設けた液洛を介して行われる。なお、この標
準電極部における実施態様は図1の場合と同様である。
This standard electrode unit has the same function as the standard electrode unit 4 of the skin surface condition measuring apparatus in FIG. 1 and can be used in place of the standard electrode unit 4 in FIG. However, communication with the culture solution is performed through the liquid electrode provided on the outer tube wall, with the standard electrode portion immersed in the culture solution. The embodiment in the standard electrode section is the same as that in FIG.

【0044】さらに、皮膚表面状態測定装置における標
準電極部として、図1の標準電極部4の内チューブ42
の部分のみ、すなわち、内チューブ42、液絡43、内
部液45、標準電極46のみからなっているものを用い
ることができる。
Further, the inner tube 42 of the standard electrode unit 4 shown in FIG.
, Ie, only the inner tube 42, the liquid junction 43, the inner liquid 45, and the standard electrode 46 can be used.

【0045】この標準電極部も、図1における皮膚表面
状態測定装置の標準電極部4と同様の機能をもって、図
1の標準電極部4に代えて使用できる。ただし、培養液
との連絡は、この標準電極部が培養液に浸漬され、チュ
ーブ壁に設けた液洛を介して行われる。なお、この標準
電極部における実施態様も図1の場合と同様である。
This standard electrode unit also has the same function as the standard electrode unit 4 of the skin surface condition measuring apparatus in FIG. 1 and can be used in place of the standard electrode unit 4 in FIG. However, communication with the culture solution is performed through the liquid electrode provided on the tube wall by immersing the standard electrode portion in the culture solution. The embodiment in the standard electrode section is the same as that in the case of FIG.

【0046】[0046]

【実施例】次に、本発明のより具体的な実施例について
説明する。
Next, more specific embodiments of the present invention will be described.

【0047】(実施例1)図1に示した皮膚表面状態測
定装置を使用し、培養液に対する皮膚表面の電位差(m
V)を測定した。測定に用いた皮膚サンプルは、ヘアレ
スマウスの皮膚切片を用い、(1)皮膚表面に何も処置
を施さないもの、(2)刺激物質であるサブスタンスP
(SP)を培養液に添加したもの、(3)SPととも
に、刺激の防御物質として知られているSPアンタゴニ
スト([D-Arg1,D-Trp7,9,Leu11]-SubstanceP)を培養
液に添加したもの、の三種類を使用した。結果を図2に
示す。
Example 1 Using the skin surface condition measuring device shown in FIG. 1, the potential difference (m
V) was measured. The skin sample used for the measurement was a skin section of a hairless mouse, and (1) a sample without any treatment on the skin surface, and (2) a substance P which is an irritant substance
(SP) added to a culture solution, and (3) cultured together with SP, an SP antagonist ([D-Arg 1 , D-Trp 7,9 , Leu 11 ] -Substance P) known as a stimulus protective substance Three types, one added to the liquid, were used. The results are shown in FIG.

【0048】図2において、横軸はSPを添加してから
の経過時間を示す。また、SPアンタゴニストを添加し
た場合は、それを加えた時点をゼロとなるようにされ
る。縦軸は電位差を示す。測定値は5回測定した平均で
表し、そのばらつきを同時に示してある。
In FIG. 2, the abscissa indicates the elapsed time after the addition of SP. When an SP antagonist is added, the time at which the SP antagonist is added is set to zero. The vertical axis indicates the potential difference. The measured values are represented by an average of five measurements, and their variations are also shown.

【0049】図2に示されたように、皮膚表面に何も処
置を施さないもの(コントロール)に対して、SPを培
養液に添加すると、電位差の急激な変化が見られる。添
加後1時間をピークとし電位差の大きな変化の状態が続
く、そして2時間後にコントロールに近い値にもどって
いる。一方、SPを添加する前にSPアンタゴニストを
培養液に添加しておくと、電位差の急激で大きな変化が
見られることなく、添加後2時間までほぼコントロール
と同じ値を示していることが分かる。このことから、S
PとともにSPアンタゴニストを添加した場合、SPア
ンタゴニストがSPによる刺激を抑制し、電位差変化を
抑制することが分かる。
As shown in FIG. 2, when SP was added to the culture solution with no treatment on the skin surface (control), a sharp change in the potential difference was observed. One hour after the addition, the state of a large change in the potential difference continues with a peak, and returns to a value close to the control 2 hours later. On the other hand, when the SP antagonist was added to the culture solution before the addition of SP, it was found that the potential difference was almost the same as that of the control until 2 hours after the addition, without a sharp change in the potential difference. From this, S
It can be seen that when an SP antagonist is added together with P, the SP antagonist suppresses SP stimulation and suppresses a potential difference change.

【0050】(実施例2)図1に示した皮膚表面状態測
定装置を使用し、培養液に対する皮膚表面の電位差(m
V)を測定した。測定に用いた皮膚サンプルは、ヘアレ
スマウスの皮膚切片を用い、(1)皮膚表面をセロテー
プでバリアー破壊(テープストリッピング)させた皮
膚、(2)テープストリッピングをした後、刺激阻害剤
として働くことが公知のカルシウムチャネルブロッカー
であるベラパミルを培養液に添加した場合の皮膚、の二
種類を使用した。結果を図3に示す。
Example 2 Using the skin surface condition measuring device shown in FIG. 1, the potential difference (m
V) was measured. The skin sample used for the measurement is a skin section of a hairless mouse, and it can act as a stimulus inhibitor after (1) skin whose cell surface is barrier-destructed (tape stripping) with cellotape, and (2) tape stripping. Two types of skin, verapamil, which is a known calcium channel blocker, was added to a culture solution. The results are shown in FIG.

【0051】図3において、横軸はテープストリッピン
グしてからの経過時間を示す。なお、経過時間ゼロの測
定値はテープストリッピングする前の皮膚の値である。
また、ベラパミルを培養液に添加した場合は、添加した
時をゼロとし、ゼロ時点の測定値はテープストリッピン
グする前の皮膚の値を示してある。縦軸は電位差を示
す。測定値は5回測定した平均で表し、そのばらつきを
同時に示してある。
In FIG. 3, the horizontal axis indicates the elapsed time after tape stripping. The measured value of the elapsed time of zero is a value of the skin before tape stripping.
When verapamil was added to the culture solution, the time at which it was added was regarded as zero, and the measured value at the time of zero indicates the value of the skin before tape stripping. The vertical axis indicates the potential difference. The measured values are represented by an average of five measurements, and their variations are also shown.

【0052】図3に示されたように、テープストリッピ
ングでの刺激によって、それ以前に比べ急激な電位差の
変化を示すことが分かる。これに対して、テープストリ
ッピング後にベラパミルを培養液に添加した場合電位差
変化を抑制する。このことから、ベラパミルがテープス
トリッピング刺激を抑制した結果、電位差変化を減少さ
せることが分かる。
As shown in FIG. 3, it can be seen that the stimulation by the tape stripping causes a sharp change in the potential difference compared to before. In contrast, when verapamil is added to the culture solution after tape stripping, the change in potential difference is suppressed. This indicates that verapamil suppresses the tape stripping stimulus, thereby reducing the change in potential difference.

【0053】(実施例3)図1に示した皮膚表面状態測
定装置を使用し、培養液に対する皮膚表面の電位差(m
V)を測定した。測定に用いた皮膚サンプルは、ヘアレ
スマウスの皮膚切片を用い、(1)皮膚表面をセロテー
プでバリアー破壊(テープストリッピング)させた皮
膚、(2)テープストリッピングをした後、カリウムチ
ャネルブロッカーであり、刺激阻害効果を示すことが分
かっているアミノピリジン(aminopylidine)(AP)
を培養液に添加した場合の皮膚、(3)テープストリッ
ピングをした後、ナトリウムチャネルブロッカーであ
り、刺激阻害効果を示さないことが分かっているテトロ
ドトキシン(tetrodotoxin)(TTX)を培養液に添加
した場合の皮膚、の三種類を使用した。結果を図4に示
す。
Example 3 Using the skin surface condition measuring device shown in FIG. 1, the potential difference (m
V) was measured. The skin sample used for the measurement was a skin section of a hairless mouse, and (1) skin in which the skin surface was subjected to barrier destruction (tape stripping) with cellotape, (2) potassium tape blocker after tape stripping, Aminopyridine (AP) known to exhibit inhibitory effects
When tetrodotoxin (TTX), which is a sodium channel blocker and shows no stimulus-inhibiting effect after tape stripping, is added to the culture solution. , Three types of skin. FIG. 4 shows the results.

【0054】図4において、横軸はテープストリッピン
グしてからの経過時間を示す。なお、経過時間ゼロの測
定値はテープストリッピングする前の皮膚の値である。
また、APあるいはTTXを培養液に添付した場合は、
添付した時をゼロとし、ゼロ時点の測定値はテープスト
リッピングする前の皮膚の値を示してある。縦軸は電位
差を示す。測定値は5回測定した平均で表し、そのばら
つきを同時に示してある。
In FIG. 4, the horizontal axis indicates the elapsed time after tape stripping. The measured value of the elapsed time of zero is a value of the skin before tape stripping.
When AP or TTX is attached to the culture solution,
The time of attachment is defined as zero, and the measured value at the time of zero indicates the value of the skin before tape stripping. The vertical axis indicates the potential difference. The measured values are represented by an average of five measurements, and their variations are also shown.

【0055】図4に示されたように、テープストリッピ
ングでの刺激によって、それ以前に比べ急激な電位差の
変化を示すことが分かる。これに対して、テープストリ
ッピング後に、APを培養液に添加した場合電位差変化
を抑制する。また、TTXを培養液に添加した場合は電
位差変化を抑制しない。これらのことから、APがテー
プストリッピング刺激を抑制した結果電位差変化を減少
させ、TTXは抑制しないので電位差変化を減少させな
いことが分かる。
As shown in FIG. 4, it can be seen that the stimulation by the tape stripping causes a sharp change in the potential difference compared to before. In contrast, when AP is added to the culture solution after tape stripping, the change in potential difference is suppressed. Further, when TTX is added to the culture solution, the change in the potential difference is not suppressed. From these results, it can be seen that the AP suppresses the tape stripping stimulus, resulting in a decrease in the potential difference change, and the TTX does not suppress the tape stripping stimulus, and thus does not reduce the potential difference change.

【0056】(実施例4)図1に示した皮膚表面状態測
定装置を使用し、培養液に対する皮膚表面の電位差(m
V)を測定した。測定に用いた皮膚サンプルは、ヘアレ
スマウスの皮膚切片を用い、(1)皮膚表面に何も処置
を施さないもの、(2)刺激物質であるカプサイシンを
皮膚表面に塗布したもの、(3)カプサイシンを皮膚表
面に塗布した後に、刺激の防御物質として知られている
カプサゼピンを塗布したもの、の三種類を使用した。結
果を図5に示す。
Example 4 Using the skin surface condition measuring device shown in FIG. 1, the potential difference (m
V) was measured. The skin sample used for the measurement was a skin section of a hairless mouse, and (1) a skin surface without any treatment, (2) a capsaicin, which is a stimulant applied to the skin surface, and (3) capsaicin. Was applied to the skin surface, and then applied with capsazepine, which is known as a protective substance against irritation. FIG. 5 shows the results.

【0057】図5において、横軸はカプサイシンを塗布
してからの経過時間を示す。また、カプサゼピンを塗布
した場合は、それを塗布した時点をゼロとなるようにさ
れる。縦軸は電位差を示す。測定値は5回測定した平均
で表し、そのばらつきを同時に示してある。
In FIG. 5, the abscissa indicates the elapsed time since the application of capsaicin. When capsazepine is applied, the time when the capsazepine is applied is set to zero. The vertical axis indicates the potential difference. The measured values are represented by an average of five measurements, and their variations are also shown.

【0058】図5に示されたように、皮膚表面に何も処
置を施さないもの(コントロール)に対して、カプサイ
シンを皮膚表面に塗布すると、電位差の急激な変化が見
られ、塗布後0.5時間に電位差の変化が最大となって
いる。一方、カプサイシンを皮膚表面に塗布した後、カ
プサゼピンを塗布すると、電位差の変化の幅が減少し、
塗布したカプサゼピンがカプサイシンによる皮膚表面の
刺激を抑制した結果、電位差変化が減少していることが
分かる。
As shown in FIG. 5, when capsaicin was applied to the skin surface in contrast to the case where no treatment was applied to the skin surface (control), a sharp change in the potential difference was observed. The change of the potential difference is maximum in 5 hours. On the other hand, if capsaicin is applied after applying capsaicin to the skin surface, the range of change in the potential difference decreases,
It can be seen that as a result of the applied capsazepine suppressing irritation of the skin surface by capsaicin, the change in potential difference is reduced.

【0059】以上の実施例の他、刺激物質として、ヒス
タミン、ドデシルベンゼンサルフェート(界面活性
剤)、乳酸(有機酸)を用いた場合も同様の結果が得ら
れた。
In addition to the above examples, similar results were obtained when histamine, dodecylbenzene sulfate (surfactant) and lactic acid (organic acid) were used as stimulants.

【0060】[0060]

【発明の効果】以上説明した通り、本発明による皮膚表
面状態測定装置によれば、培養液の液面に表面を上にし
て皮膚切片を浮かべた皮膚モデルを作成し、その皮膚表
面と培養液との電位差を簡便に測定することができる。
また、刺激要因を皮膚表面あるいは培養液に付与するこ
とにより、皮膚表面と培養液との電位差が増大し、皮膚
に与える刺激度を確認できる。さらに、刺激防御物質を
皮膚に刺激要因を与える前後に、塗布したり、培養液に
添加したりすることにより電位差の変化の度合が減少
し、皮膚刺激に対する抑制物質を探索することができ
る。
As described above, according to the skin surface condition measuring apparatus of the present invention, a skin model in which a skin slice is floated with the surface facing upward on the liquid surface of the culture solution is prepared, and the skin surface and the culture solution are formed. Can be easily measured.
In addition, by applying a stimulating factor to the skin surface or the culture solution, the potential difference between the skin surface and the culture solution increases, and the degree of irritation applied to the skin can be confirmed. Furthermore, by applying or adding a stimulus-protecting substance to the skin before and after giving a stimulating factor to the skin, the degree of change in the potential difference is reduced, and a substance that inhibits skin irritation can be searched for.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施の形態にかかる皮膚表面状態測定
装置の例を示す図である。
FIG. 1 is a diagram showing an example of a skin surface state measuring device according to an embodiment of the present invention.

【図2】本発明による皮膚表面状態測定装置を使用して
培養液に対する皮膚表面電位差を測定した結果の例を示
すグラフである。
FIG. 2 is a graph showing an example of a result of measuring a skin surface potential difference with respect to a culture solution using the skin surface condition measuring device according to the present invention.

【図3】本発明による皮膚表面状態測定装置を使用して
培養液に対する皮膚表面電位差を測定した結果の他の例
を示すグラフである。
FIG. 3 is a graph showing another example of a result of measuring a skin surface potential difference with respect to a culture solution using the skin surface condition measuring device according to the present invention.

【図4】本発明による皮膚表面状態測定装置を使用して
培養液に対する皮膚表面電位差を測定した結果の他の例
を示すグラフである。
FIG. 4 is a graph showing another example of a result of measuring a skin surface potential difference with respect to a culture solution using the skin surface condition measuring apparatus according to the present invention.

【図5】本発明による皮膚表面状態測定装置を使用して
培養液に対する皮膚表面電位差を測定した結果の他の例
を示すグラフである。
FIG. 5 is a graph showing another example of a result of measuring a skin surface potential difference with respect to a culture solution using the skin surface condition measuring apparatus according to the present invention.

【符号の説明】[Explanation of symbols]

1…培養液 2…皮膚切片 3…容器 4…標準電極部 5…測定電極部 6…電位差検出部 7、8…塩橋 9…ろ紙 41、51…外チューブ 42、52…内チューブ 43、53…液絡 44、45、54、55…内部液 46…標準電極 47、57…電極ホルダ 48、58…液補充口 56…測定電極 DESCRIPTION OF SYMBOLS 1 ... Culture liquid 2 ... Skin slice 3 ... Container 4 ... Standard electrode part 5 ... Measurement electrode part 6 ... Potential difference detecting part 7,8 ... Shiohashi 9 ... Filter paper 41,51 ... Outer tube 42,52 ... Inner tube 43,53 ... liquid junction 44, 45, 54, 55 ... internal liquid 46 ... standard electrode 47, 57 ... electrode holder 48, 58 ... liquid replenishing port 56 ... measuring electrode

───────────────────────────────────────────────────── フロントページの続き (72)発明者 井上 かおり 神奈川県横浜市金沢区福浦2−12−1 株 式会社資生堂第二リサーチセンター内 Fターム(参考) 2G045 AA40 CB09 FB05 GC18  ────────────────────────────────────────────────── ─── Continued on the front page (72) Inventor Kaori Inoue 2-12-1 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa F-term in Shiseido Second Research Center Co., Ltd. (Reference) 2G045 AA40 CB09 FB05 GC18

Claims (22)

【特許請求の範囲】[Claims] 【請求項1】 容器内に収容した培養液の液面に表面を
上にして皮膚切片を浮かべ、この皮膚切片の皮膚表面と
前記培養液との電位差を測定することを特徴とする皮膚
表面状態の測定方法。
1. A skin surface condition wherein a skin slice is floated on a liquid surface of a culture solution contained in a container with its surface facing upward, and a potential difference between the skin surface of the skin slice and the culture solution is measured. Measurement method.
【請求項2】 前記培養液が、生理食塩水又はアミノ酸
類を含む培養液である請求項1記載の皮膚表面状態の測
定方法。
2. The method according to claim 1, wherein the culture solution is a culture solution containing physiological saline or amino acids.
【請求項3】 容器内に収容した培養液の液面に表面を
上にして皮膚切片を浮かべ、この皮膚切片の皮膚表面と
前記培養液との電位差を測定するに当たって、皮膚表面
に刺激を与えて電位差を測定し、その値と、刺激を与え
ない場合の電位差との差から、皮膚の刺激度を測定する
方法。
3. A skin slice is floated on the surface of a culture solution contained in a container with its surface facing upward, and when measuring a potential difference between the skin surface of the skin slice and the culture solution, stimulation is applied to the skin surface. A method of measuring the skin potential from the difference between the measured potential difference and the potential difference when no stimulation is applied.
【請求項4】 前記刺激が、刺激物質によることを特徴
とする請求項3記載の皮膚の刺激度を測定する方法。
4. The method according to claim 3, wherein the stimulus is a stimulus substance.
【請求項5】 前記刺激が、物理的刺激である請求項3
記載の皮膚の刺激度を測定する方法。
5. The stimulus according to claim 3, wherein the stimulus is a physical stimulus.
The method for measuring the degree of skin irritation described in the above.
【請求項6】 容器内に収容した培養液の液面に表面を
上にして皮膚切片を浮かべ、この皮膚切片の皮膚表面と
前記培養液との電位差を測定するに当たって、培養液に
刺激物質を添加して電位差を測定し、その値と、刺激物
質を添加しない場合の電位差との差から、皮膚の刺激度
を測定する方法。
6. A skin slice is floated on the surface of a culture solution contained in a container with its surface facing upward, and when measuring the potential difference between the skin surface of the skin slice and the culture solution, an irritant is added to the culture solution. A method in which the potential difference is measured after addition, and the degree of skin irritation is measured from the difference between the value and the potential difference when no stimulant is added.
【請求項7】 前記刺激物質が、皮膚に対するかゆみ発
生物質である請求項4または6記載の皮膚の刺激度を測
定する方法。
7. The method for measuring the degree of skin irritation according to claim 4, wherein the irritant is an itch-producing substance for the skin.
【請求項8】 前記培養液が、生理食塩水又はアミノ酸
類を含む培養液である請求項3乃至7のいずれか一項に
記載の皮膚の刺激度を測定する方法。
8. The method for measuring the degree of skin irritation according to claim 3, wherein the culture solution is a culture solution containing physiological saline or amino acids.
【請求項9】 容器内に収容した培養液の液面に表面を
上にして刺激を与えた皮膚切片を浮かべ、この皮膚切片
の皮膚表面と前記培養液との電位差を測定するに当たっ
て、皮膚表面に刺激を与える前あるいは後に、その皮膚
表面に薬剤を塗布して電位差を測定し、その値と、薬剤
を塗布しない場合の電位差との差から、薬剤による皮膚
刺激の抑制度を測定する方法。
9. A stimulated skin slice is floated on the surface of a culture solution contained in a container with its surface facing upward, and the skin surface is measured when measuring the potential difference between the skin surface of the skin slice and the culture solution. A method of measuring the potential difference by applying a drug to the skin surface before or after applying a stimulus to the skin, and measuring the degree of inhibition of skin irritation by the drug from the difference between the value and the potential difference when the drug is not applied.
【請求項10】 容器内に収容した培養液の液面に表面
を上にして刺激を与えた皮膚切片を浮かべ、この皮膚切
片の皮膚表面と前記培養液との電位差を測定するに当た
って、皮膚表面に刺激を与える前あるいは後に、培養液
に薬剤を添加して電位差を測定し、その値と、薬剤を添
加しない場合の電位差との差から、薬剤による皮膚刺激
の抑制度を測定する方法。
10. A stimulated skin slice is floated on the surface of a culture solution contained in a container with its surface facing upward, and the skin surface is measured when measuring the potential difference between the skin surface of the skin slice and the culture solution. A method in which a potential difference is measured by adding a drug to a culture solution before or after stimulating the skin, and the degree of inhibition of skin irritation by the drug is measured from the difference between the value and the potential difference when the drug is not added.
【請求項11】 前記刺激が、刺激物質によることを特
徴とする請求項9または10記載の皮膚刺激の抑制度を
測定する方法。
11. The method according to claim 9, wherein the stimulus is a stimulus substance.
【請求項12】 前記刺激が、物理的刺激である請求項
9または10記載の皮膚刺激の抑制度を測定する方法。
12. The method according to claim 9, wherein the stimulus is a physical stimulus.
【請求項13】 容器内に収容した刺激物質を添加した
培養液の液面に表面を上にして皮膚切片を浮かべ、この
皮膚切片の皮膚表面と前記培養液との電位差を測定する
に当たって、培養液に刺激物質を添加する前あるいは後
に、その皮膚表面に薬剤を塗布して電位差を測定し、そ
の値と、薬剤を塗布しない場合の電位差との差から、薬
剤による皮膚刺激の抑制度を測定する方法。
13. A skin slice is floated on a liquid surface of a culture solution to which a stimulant substance contained in a container is added, with the surface thereof facing upward, and in measuring the potential difference between the skin surface of the skin slice and the culture solution, the culture is performed. Before or after adding the stimulant to the solution, apply the drug to the skin surface and measure the potential difference, and measure the degree of inhibition of skin irritation by the drug from the difference between the value and the potential difference when the drug is not applied how to.
【請求項14】 容器内に収容した刺激物質を添加した
培養液の液面に表面を上にして皮膚切片を浮かべ、この
皮膚切片の皮膚表面と前記培養液との電位差を測定する
に当たって、培養液に刺激物質を添加する前あるいは後
に、培養液に薬剤を添加して電位差を測定し、その値
と、刺激物質を添加しない場合の電位差との差から、薬
剤による皮膚刺激の抑制度を測定する方法。
14. A skin slice is floated on a liquid surface of a culture solution to which a stimulant substance contained in a container is added, with the surface thereof facing upward, and when measuring a potential difference between the skin surface of the skin slice and the culture solution, culture is performed. Before or after adding the stimulant to the solution, add a drug to the culture solution and measure the potential difference, and measure the degree of inhibition of skin irritation by the drug from the difference between that value and the potential difference when no stimulant is added how to.
【請求項15】 前記刺激物質が、皮膚に対するかゆみ
発生物質である請求項11または13または14記載の
皮膚刺激の抑制度を測定する方法。
15. The method for measuring the degree of inhibition of skin irritation according to claim 11, wherein the stimulant is an itch-producing substance for the skin.
【請求項16】 前記培養液が、生理食塩水又はアミノ
酸類を含む培養液である請求項9乃至15のいずれか一
項に記載の皮膚刺激の抑制度を測定する方法。
16. The method for measuring the degree of suppression of skin irritation according to any one of claims 9 to 15, wherein the culture solution is a culture solution containing physiological saline or amino acids.
【請求項17】 培養液と、その液面に表面を上にして
浮かべた皮膚切片を収容した容器と、前記培養液に連絡
される標準電極部と、前記皮膚切片の皮膚表面に連絡さ
れる測定電極部と、前記標準電極部と前記測定電極部と
の電位差を検出する電位差検出部とを備えたことを特徴
とする皮膚表面状態測定装置。
17. A container containing a culture solution, a skin slice floating above the liquid surface, a standard electrode portion connected to the culture solution, and a skin surface of the skin slice. A skin surface condition measuring device comprising: a measuring electrode unit; and a potential difference detecting unit that detects a potential difference between the standard electrode unit and the measuring electrode unit.
【請求項18】 前記標準電極部が、標準電極が浸漬さ
れた内部液を収容した内チューブと、この内チューブを
中に収納し二重チューブを形成する、内部液を収容した
外チューブとを備え、前記内チューブ壁には液絡が被着
されてなることを特徴とする標準電極部である請求項1
7記載の皮膚表面状態測定装置。
18. The standard electrode part comprises: an inner tube containing an internal liquid in which a standard electrode is immersed; and an outer tube containing an internal liquid, which contains the inner tube and forms a double tube. 2. A standard electrode part, wherein a liquid junction is attached to the inner tube wall.
A skin surface condition measuring device according to claim 7.
【請求項19】 前記培養液と標準電極部との連絡が、
前記培養液と、前記外チューブ内の内部液との間に結ば
れた塩橋によることを特徴とする請求項18記載の皮膚
表面状態測定装置。
19. The communication between the culture solution and a standard electrode unit,
19. The skin surface condition measuring device according to claim 18, wherein a salt bridge is connected between the culture solution and the internal solution in the outer tube.
【請求項20】 前記測定電極部が、測定電極が浸漬さ
れた内部液を収容した内チューブと、この内チューブを
中に収納し二重チューブを形成する、内部液を収容した
外チューブとを備え、前記内チューブ壁には液絡が被着
されてなることを特徴とする測定電極部である請求項1
7乃至19のいずれか一項に記載の皮膚表面状態測定装
置。
20. The measurement electrode section comprising: an inner tube containing an internal liquid in which the measurement electrode is immersed; and an outer tube containing the internal liquid, which contains the inner tube to form a double tube. 2. A measurement electrode unit, wherein a liquid junction is provided on the inner tube wall.
The skin surface condition measuring device according to any one of claims 7 to 19.
【請求項21】 前記皮膚切片の皮膚表面と測定電極部
との連絡が、前記皮膚切片の皮膚表面と、前記外チュー
ブ内の内部液との間に結ばれた塩橋によることを特徴と
する請求項20記載の皮膚表面状態測定装置。
21. The communication between the skin surface of the skin slice and the measurement electrode unit is by a salt bridge connected between the skin surface of the skin slice and the internal liquid in the outer tube. The skin surface condition measuring device according to claim 20.
【請求項22】 前記培養液が、生理食塩水又はアミノ
酸類を含む培養液である請求項17乃至21のいずれか
一項に記載の皮膚表面状態測定装置。
22. The skin surface condition measuring device according to claim 17, wherein the culture solution is a culture solution containing physiological saline or amino acids.
JP2000252732A 2000-08-23 2000-08-23 Method and apparatus for measuring skin surface condition Expired - Lifetime JP3860956B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2000252732A JP3860956B2 (en) 2000-08-23 2000-08-23 Method and apparatus for measuring skin surface condition
US10/362,127 US20040106877A1 (en) 2000-08-23 2001-08-21 Method and device for determining state of skin surface
PCT/JP2001/007142 WO2002016933A1 (en) 2000-08-23 2001-08-21 Method and device for determining state of skin surface
EP01956991A EP1314979B1 (en) 2000-08-23 2001-08-21 Method and device for determining state of skin surface
DE60136195T DE60136195D1 (en) 2000-08-23 2001-08-21 METHOD AND DEVICE FOR DETERMINING THE CONDITION OF THE SKIN SURFACE
EP07008527A EP1811296A1 (en) 2000-08-23 2001-08-21 Methods and apparatus for measuring skin surface condition
KR10-2003-7002542A KR100880560B1 (en) 2000-08-23 2001-08-21 Method and device for determining state of electric potential of skin surface
TW090120657A TW584725B (en) 2000-08-23 2001-08-22 Methods and apparatus for measuring skin surface condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000252732A JP3860956B2 (en) 2000-08-23 2000-08-23 Method and apparatus for measuring skin surface condition

Publications (2)

Publication Number Publication Date
JP2002062294A true JP2002062294A (en) 2002-02-28
JP3860956B2 JP3860956B2 (en) 2006-12-20

Family

ID=18741931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000252732A Expired - Lifetime JP3860956B2 (en) 2000-08-23 2000-08-23 Method and apparatus for measuring skin surface condition

Country Status (1)

Country Link
JP (1) JP3860956B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002103351A1 (en) * 2001-06-14 2002-12-27 Shiseido Company, Ltd. Method of detecting skin stimulation effect
WO2005080977A1 (en) * 2004-02-24 2005-09-01 Rohto Pharmaceutical Co., Ltd. Method of estimating skin irritation
JP2016191673A (en) * 2015-03-31 2016-11-10 一丸ファルコス株式会社 Method of evaluating or selecting anti-inflammatory agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002103351A1 (en) * 2001-06-14 2002-12-27 Shiseido Company, Ltd. Method of detecting skin stimulation effect
WO2005080977A1 (en) * 2004-02-24 2005-09-01 Rohto Pharmaceutical Co., Ltd. Method of estimating skin irritation
JP2016191673A (en) * 2015-03-31 2016-11-10 一丸ファルコス株式会社 Method of evaluating or selecting anti-inflammatory agents

Also Published As

Publication number Publication date
JP3860956B2 (en) 2006-12-20

Similar Documents

Publication Publication Date Title
Hughes et al. A fresh look at iontophoresis
Solandt The measurement of “accommodation” in nerve
Karande et al. Discovery of transdermal penetration enhancers by high-throughput screening
JP3916658B2 (en) Measuring moisture in the skin
US6361665B1 (en) Device for electroactivating fluids and preparations consisting of electroactivated fluids
Peterson et al. A two-dimensional random-walk analysis of human granulocyte movement
Beck et al. Regulation of basolateral K channels in proximal tubule studied during continuous microperfusion
CN108780085A (en) Advanced electroporation device and method for obtaining the analyte in biofluid
Konishi et al. Effects of exposure to noise on ion movement in guinea pig cochlea
Tronstad et al. Waveform difference between skin conductance and skin potential responses in relation to electrical and evaporative properties of skin
Baimoukhametova et al. Dopamine modulates use-dependent plasticity of inhibitory synapses
Alreja et al. Noradrenaline induces IPSCs in rat medial septal/diagonal band neurons: involvement of septohippocampal GABAergic neurons.
JP2002062294A (en) Method and device for measuring skin surface condition
Leng et al. Effects of raised extracellular potassium on the excitability of, and hormone release from, the isolated rat neurohypophysis.
Zeuthen Intracellular gradients of ion activities in the epithelial cells of the Necturus gallbladder recorded with ion-selective microelectrodes
Fujimoto et al. Field potentials induced by injection of potassium ion into the frog retina: A test of current interpretations of the electroretinographic (ERG) b-wave
Koide et al. XXVII Studies on the Oxigraphic Measurement of the Oxygen Tension in the Labyrinth: Preliminary Report
SE455919B (en) PREPARATION FOR REDUCING OGATS INTRAOCULATE PRESSURE CONTAINING SULPHONAMIDE
WO2002016933A1 (en) Method and device for determining state of skin surface
McClendon et al. The psychogalvanic reflex as related to the polarization-capacity of the skin
JP2006524118A (en) Pad for cleansing and hydrating the skin
JP4608085B2 (en) Method and apparatus for measuring skin surface potential state
CN110856695A (en) Application of hot spring water in cosmetics
Huangfu et al. Dynamics of the flow of perilymph in the cochlea of the guinea pig
JP6478695B2 (en) Evaluation method of test substance and hypoosmotic stimulation inhibitor

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050706

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060925

R150 Certificate of patent or registration of utility model

Ref document number: 3860956

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100929

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100929

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110929

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120929

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120929

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130929

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term